|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
regulation of apoptosis
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
380:958-971
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1.
|
|
C.L.Day,
C.Smits,
F.C.Fan,
E.F.Lee,
W.D.Fairlie,
M.G.Hinds.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Pro-survival proteins in the B-cell lymphoma-2 (Bcl-2) family have a defined
specificity profile for their cell death-inducing BH3-only antagonists. Solution
structures of myeloid cell leukaemia-1 (Mcl-1) in complex with the BH3 domains
from Noxa and Puma, two proteins regulated by the tumour suppressor p53, show
that they bind as amphipathic alpha-helices in the same hydrophobic groove of
Mcl-1, using conserved residues for binding. Thermodynamic parameters for the
interaction of Noxa, Puma and the related BH3 domains of Bmf, Bim, Bid and Bak
with Mcl-1 were determined by calorimetry. These unstructured BH3 domains bind
Mcl-1 with affinities that span 3 orders of magnitude, and binding is an
enthalpically driven and entropy-enthalpy-compensated process. Alanine scanning
analysis of Noxa demonstrated that only a subset of residues is required for
interaction with Mcl-1, and these residues are localised to a short highly
conserved sequence motif that defines the BH3 domain. Chemical shift mapping of
Mcl-1:BH3 complexes showed that Mcl-1 engages all BH3 ligands in a similar way
and that, in addition to changes in the immediate vicinity of the binding site,
small molecule-wide structural adjustments accommodate ligand binding. Our
studies show that unstructured peptides, such as the BH3 domains, behave like
their structured counterparts and can bind tightly and selectively in an
enthalpically driven process.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Fig. 3. Comparison of backbone conformations of Mcl-1:Puma
with other Bcl-2 proteins. The backbone ribbon of Mcl-1:Puma
(PDB code 2ROC) is shown in gray in all panels, and the
orientation of the Mcl-1 is the same as that in Fig. 2b. (a)
Unliganded Mcl-1 (PDB code 1WSX^15) in gold. The positions of
H205 and H233 are shown. (b) Bcl-x[L]:Bim (PDB code 1PQ1^9) in
pink (BH3 ligands not shown). (c) A1:Puma (PDB code 2VOF^19) in
green. (d) Unliganded Bcl-x[L] (PDB code 1PQ0^9) in blue.
|
 |
Figure 5.
Fig. 5. BH3 domains are unstructured in solution. (a) Detail
of NoxaB binding Mcl-1 (PDB code 2NL9^10) showing the NWGR motif
of the BH1 domain α5 and the N-capping interaction. The side
chain of N260 forms a hydrogen bond with R263 HN, and an
intermolecular N-cap occurs between the side chains of N70 and
G262. The BH3 helix is coloured yellow, and the key side chains
are illustrated. (b) CD spectra of the BH3 domains for Puma
(orange), NoxaA (blue), NoxaB (red) and Bim (green) are shown in
the presence (square/line) and in the absence (line only) of 30%
trifluoroethanol.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2008,
380,
958-971)
copyright 2008.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
E.A.Brem,
K.Thudium,
S.Khubchandani,
P.C.Tsai,
S.H.Olejniczak,
S.Bhat,
W.Riaz,
J.Gu,
A.Iqbal,
R.Campagna,
J.Knight,
C.Mavis,
P.Hoskin,
G.Deeb,
J.F.Gibbs,
G.Fetterly,
M.S.Czuczman,
and
F.J.Hernandez-Ilizaliturri
(2011).
Distinct cellular and therapeutic effects of obatoclax in rituximab-sensitive and -resistant lymphomas.
|
| |
Br J Haematol, 153,
599-611.
|
 |
|
|
|
|
 |
E.F.Lee,
O.B.Clarke,
M.Evangelista,
Z.Feng,
T.P.Speed,
E.B.Tchoubrieva,
A.Strasser,
B.H.Kalinna,
P.M.Colman,
and
W.D.Fairlie
(2011).
Discovery and molecular characterization of a Bcl-2-regulated cell death pathway in schistosomes.
|
| |
Proc Natl Acad Sci U S A, 108,
6999-7003.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.Schreiber,
and
A.E.Keating
(2011).
Protein binding specificity versus promiscuity.
|
| |
Curr Opin Struct Biol, 21,
50-61.
|
 |
|
|
|
|
 |
E.Fire,
S.V.Gullá,
R.A.Grant,
and
A.E.Keating
(2010).
Mcl-1-Bim complexes accommodate surprising point mutations via minor structural changes.
|
| |
Protein Sci, 19,
507-519.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.Gavathiotis,
D.E.Reyna,
M.L.Davis,
G.H.Bird,
and
L.D.Walensky
(2010).
BH3-triggered structural reorganization drives the activation of proapoptotic BAX.
|
| |
Mol Cell, 40,
481-492.
|
 |
|
|
|
|
 |
G.J.Rautureau,
C.L.Day,
and
M.G.Hinds
(2010).
Intrinsically disordered proteins in bcl-2 regulated apoptosis.
|
| |
Int J Mol Sci, 11,
1808-1824.
|
 |
|
|
|
|
 |
K.J.Campbell,
M.L.Bath,
M.L.Turner,
C.J.Vandenberg,
P.Bouillet,
D.Metcalf,
C.L.Scott,
and
S.Cory
(2010).
Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.
|
| |
Blood, 116,
3197-3207.
|
 |
|
|
|
|
 |
M.L.Stewart,
E.Fire,
A.E.Keating,
and
L.D.Walensky
(2010).
The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer.
|
| |
Nat Chem Biol, 6,
595-601.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.J.Falconer,
A.Penkova,
I.Jelesarov,
and
B.M.Collins
(2010).
Survey of the year 2008: applications of isothermal titration calorimetry.
|
| |
J Mol Recognit, 23,
395-413.
|
 |
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2010).
Grading the commercial optical biosensor literature-Class of 2008: 'The Mighty Binders'.
|
| |
J Mol Recognit, 23,
1.
|
 |
|
|
|
|
 |
S.Dutta,
S.Gullá,
T.S.Chen,
E.Fire,
R.A.Grant,
and
A.E.Keating
(2010).
Determinants of BH3 binding specificity for Mcl-1 versus Bcl-xL.
|
| |
J Mol Biol, 398,
747-762.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.F.Lee,
A.Fedorova,
K.Zobel,
M.J.Boyle,
H.Yang,
M.A.Perugini,
P.M.Colman,
D.C.Huang,
K.Deshayes,
and
W.D.Fairlie
(2009).
Novel Bcl-2 homology-3 domain-like sequences identified from screening randomized peptide libraries for inhibitors of the pro-survival Bcl-2 proteins.
|
| |
J Biol Chem, 284,
31315-31326.
|
 |
|
|
|
|
 |
E.F.Lee,
P.E.Czabotar,
H.Yang,
B.E.Sleebs,
G.Lessene,
P.M.Colman,
B.J.Smith,
and
W.D.Fairlie
(2009).
Conformational changes in Bcl-2 pro-survival proteins determine their capacity to bind ligands.
|
| |
J Biol Chem, 284,
30508-30517.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Oda,
M.Schröder,
and
A.R.Khan
(2009).
Structural basis for targeting of human RNA helicase DDX3 by poxvirus protein K7.
|
| |
Structure, 17,
1528-1537.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.Yao,
A.A.Bobkov,
L.A.Plesniak,
and
F.M.Marassi
(2009).
Mapping the interaction of pro-apoptotic tBID with pro-survival BCL-XL.
|
| |
Biochemistry, 48,
8704-8711.
|
 |
|
|
|
|
 |
E.Lomonosova,
and
G.Chinnadurai
(2008).
BH3-only proteins in apoptosis and beyond: an overview.
|
| |
Oncogene, 27,
S2-19.
|
 |
|
|
|
|
 |
J.Yu,
and
L.Zhang
(2008).
PUMA, a potent killer with or without p53.
|
| |
Oncogene, 27,
S71-S83.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|